rHu Albumin Market
Overview:
Recombinant human albumin is structurally comparable product to original human serum albumin however, as the original HSA, it doesn’t comprises any animal components. This product can be produced without requiring any ingredients coming from humans and animals. It an animal-free product, which is highly efficient than human serum albumin that are derived from plasma. This product is largely used in cell culture applications.
The Global rHu Albumin Market is expected to have a value of US$ 84.9 Mn in 2022, and is estimated to show a CAGR of 10.0 % during the forecast period (2022-2030).
To Get More Business Strategies Request Free Sample Copy of This Research Report:) @ https://www.coherentmarketinsights.com/insight/request-sample/5040
Market Drivers:
The number of research and clinical trials in rHu albumin is increasing around the world, which is expected to propel growth of the global rHu albumin market over the forecast period. For instance, Shilpa Medicare Limited, received approval for a Phase 1 human trial from Central Drugs Standard Control Organization for its new product NavAlbumin, recombinant Human Albumin.
Moreover, rise in benefits of recombinant human serum albumin over animal or human serum albumin are likely to boost growth of the global rHu albumin market over the forecast period. It eases issues related to standard procurement techniques of albumin, it contains no animal products and offers reliable supply, greater purity, high homogeneity and more. Moreover, it prevent aggregation, oxidation, adsorption, and fibrillation. Its introduction in the stem cell cultivation enhanced culture media control, which regulatory bodies favors as they offer comprehensive quality data.
Impact of COVID-19:
The epidemic of COVID-19 significantly impacted the rHu albumin market. The virus outbreak in China spread across more than 200 countries around the world. Several countries implemented stringent lockdown regulations to control the virus spread due to which several market activities were suspended during the pandemic. However, research activities for vaccine development continued to growth in this period. rHu albumin was high in demand due to its application in production of vaccine. Market players were focusing on use of rHu albumin in vaccines as a stabilizer. For instance, a biotech company, Albumedix Ltd. started offering recombinant human serum, Recombumin for vaccine production.
For More Information or Query or Customization before Buying, Visit at – https://www.coherentmarketinsights.com/insight/talk-to-analyst/5040
Regional Insights:
North America among regions is anticipated to witness significant growth in the global rHu albumin market over the forecast period. This growth can be attributed to increasing number of market players focusing on adoption growth strategies such as expansion of manufacturing plants to strengthen their portfolio. For instance, InVitria, expanded its facility in Munich, Germany, to enhance customer experience and offer a local supply in UK.
Furthermore, Europe is alos anticipated to witness robust growth in the global rHu albumin market over the forecast period, due to rise in R&D activities for rHu albumin. For instance, in March 2021, clinicaltrials.gov published a study from University Hospital, Belgium, for investigating human albumin in patients with reported repeated failures in implantation on birth.
Key Players:
Key players functioning in the global rHu albumin market are Shandong Kingtone Biotechnology Co.,Ltd., Merck KGaA, Abcam Plc, HiMedia Laboratories Pvt. Ltd., Lee Biosolutions, Inc., Albumin Bioscience, Lazuline Biotech Private Limited, Albumedix, InVitria, and ScienCell Research Laboratories, Inc.
Grab the Offer and Get FLAT 30% Discount on This Research Report 2022-2028 @ https://www.coherentmarketinsights.com/promo/buynow/5040
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Source
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Porter’s Analysis
- Industry Trends
- Key Highlights
- Epidemiology
- Reimbursement Scenario
- Regulatory Scenario
- Product Launch and Approvals
- Acquisition and Collaboration Scenario
- Market Dynamics
- Global rHu Albumin Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of rHu Albumin
- Impact of COVID-19 on the overall Healthcare Sector
- Global rHu Albumin Market , By Source, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Oryza Sativa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Pichia pastoris
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Introduction
- Global rHu Albumin Market , By Application, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Cell Culture Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Nutrient and stabilizer
- Medium Supplement
- Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Drug Formulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Cryopreservation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Introduction
- Global rHu Albumin Market , By End User, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Pharmaceutical & Biotechnology Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/rhu-albumin-market-4319
𝗔𝗯𝗼𝘂𝘁 𝗨𝗦:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝘀:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837